T2 Biosystems, an in vitro diagnostics company, develops diagnostic products. It provides T2 Magnetic Resonance platform that enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, and urine.            ...

Myriad Genetics, a personalized medicine company, focuses on the development of predictive, personalized, and prognostic genetic diagnostics.            ...

Coal is a dying industry due to rapidly declining costs curves for solar power. Our short of KOL, the Coal Mining ETF, is a diversified way to benefit from coal's obsolescence.            ...

O'Reilly Automotive Inc. sells auto parts. They will be a victim of self-driving electric cars. Self-driving cars mean less cars on the road. Electric cars have far less moving parts and don't break down like gas powered vehicles. In short, the need for auto parts will plummet over the next few years. At the time we shorted ORLY, it was trading at a P/E of 27 - extremely expensive relative to its future prospects.            ...

Our position in GLD, the Gold ETF, is driven almost entirely by technical patterns.            ...